CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · New debt or obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-A12B Other Registration of Securities
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 11 of 24 · 467 filings